Description

Koselugo is a medication used for the treatment of neurofibromatosis type 1 in pediatric patients. It works by inhibiting the growth of tumors associated with this genetic disorder.

Interpreter Notes

Interpreters should be aware that the term 'Koselugo' may be used interchangeably with its generic name, selumetinib, in some contexts. It is important to maintain a formal register and avoid colloquial terms when discussing this medication. Ensure clarity when explaining its use in specific patient populations.

Example Sentences

EN: The doctor prescribed Koselugo to manage the patient's neurofibromatosis symptoms.

ES: El médico recetó Koselugo para manejar los síntomas de neurofibromatosis en el paciente.

Common Interpreter Mistakes

Confusing Koselugo with other cancer treatments; mispronouncing the name leading to misunderstandings; using informal language when discussing a medication.